Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of Lung Cancer
1009-3419
2005 Issue 6
e xing lin ba liu he bing fei ai yi li bao gao
zhou li qiang ; yan hao
..............page:534
shuang fei zhan ye biao pi yang ai yi li bao gao
gong zuo ning ; pu shang ; wang xiao lian ; zhao fu xin ; yuan fu xiang
..............page:526
fei ai he bing ji xing li - dan he xi bao xing bai xue bing yi li
zhao yan feng ; jiang da
..............page:513
zhong liu huai si yin zi dui fei ai suo zhi de nan zhi xing xiong qiang ji ye de liao xiao guan cha
zhong li song ; zhao lei ; zhang qian shi ; jiang lie hong
..............page:522
zhong liu biao zhi wu lian he jian ce zai fei ai zhen zhi zhong de jia zhi
guo lin ; zuo gui lan ; xu xiao feng ; jiang guo ; fu xiao long
..............page:544-546
Clinical analysis of 58 surgically treated patients with bronchioloalveolar carcinoma
WU Jianbo;LI Taoyuan;DIAO Li
..............page:542-543
Evaluation on survival in locally advanced non-small cell lung cancer (NSCLC) for multimodality treatment with or without operation
LI Jinhan;MA Shudong;KANG Shijun;XIE Jianming;SHENG Xinxiu;LUO Rongcheng
..............page:535-537
Expression of Kail and FasL in non-small cell lung cancer and its clinicopathological significance
LI Yuanhang;WU Dongying;ZHENG Huachuan;XIN Yan
..............page:518-522
Effects of bisphosphonates on proliferation of lung cancer cells in vitro
LIN Xiufeng;YU Huixin;TAN Cheng;CHEN Bo;WANG Tiesheng;WANG Bocheng
..............page:510-513
Effects of targeting inhibition of ERK1/2 signal transduction pathway on malignant biological behaviors of human high-metastatic large cell lung cancer cell line L9981
LI Yin;ZHOU Qinghua;SUN Zhilin;SUN Zefang;WANG Yanping;QIN Yang;ZHU Wen;CHEN Xiaohe
..............page:504-509
e xing xiong mo jian pi liu de zhen zhi jin zhan
liang zhi xin ; chen liang an
..............page:574-576
fei ai fen zi yu hou fen xi
cui yong ; wang tian you
..............page:570-573
fei ai yu cox-2 de yan jiu xian zhuang
wang mao hua ; hong zhi peng
..............page:567-569
ssh ji shu ji qi zai zhong liu yan jiu zhong de ying yong
ma jia bao ; zhou qing hua
..............page:563-566
zhong guo fei ai wai ke zhi liao gai kuang yu jin zhan
zhang de chao ; mao you sheng ; huang guo jun
..............page:557-562
yi li ti kang wei zhu lian he zhi liao wan qi fei ai de hu li
yuan ling ; li hong ; diao yong shu
..............page:555-556
fei ai he bing shang qiang jing mai zong he zheng de hua liao hu li
xiang qiu fen ; li jun ying ; wang juan
..............page:553-554
fei jian zhi xian wei hua he bing fei ai si li lin chuang jing yan zong jie
wu chi ; yang xian feng ; li long zuo
..............page:550-552
ju bu wan qi fei xiao xi bao fei ai tong bu fang hua liao sui ji dui zhao lin chuang shi yan
sun zhi hua ; yu shi ying ; liu ying jie ; wang zuo
..............page:547-549
Inhibition of mouse Lewis lung cancer via intravenous administration of recombinant mouse sFlt1 adenovirus
KAN Bing;JIANG Yu;YANG Jinliang;CHEN Xiancheng;HU Min;WEI Yuquan
..............page:501-503
Inhibition of human lung adenocarcinoma cells by 5F11-doxorubicin immunoconjugate in vitro and in vivo
ZHANG Tongmei;LAI Baitang;ZHAN Xiuping
..............page:495-500
Optimizing the methods of whole lung cancer RNA-loaded dendritic cells
WANG Kun;WU Yilong;ZHOU Qing;XU Chongrui;LIN Jiaying;YANG Xuening;HUANG Shaoqiong
..............page:489-494